Correlation Between Microsoft and Relief Therapeutics
Can any of the company-specific risk be diversified away by investing in both Microsoft and Relief Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Relief Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Relief Therapeutics Holding, you can compare the effects of market volatilities on Microsoft and Relief Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Relief Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Relief Therapeutics.
Diversification Opportunities for Microsoft and Relief Therapeutics
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Microsoft and Relief is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Relief Therapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relief Therapeutics and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Relief Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relief Therapeutics has no effect on the direction of Microsoft i.e., Microsoft and Relief Therapeutics go up and down completely randomly.
Pair Corralation between Microsoft and Relief Therapeutics
Given the investment horizon of 90 days Microsoft is expected to generate 0.14 times more return on investment than Relief Therapeutics. However, Microsoft is 7.2 times less risky than Relief Therapeutics. It trades about 0.48 of its potential returns per unit of risk. Relief Therapeutics Holding is currently generating about -0.07 per unit of risk. If you would invest 41,696 in Microsoft on September 20, 2024 and sell it today you would earn a total of 3,750 from holding Microsoft or generate 8.99% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Microsoft vs. Relief Therapeutics Holding
Performance |
Timeline |
Microsoft |
Relief Therapeutics |
Microsoft and Relief Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Microsoft and Relief Therapeutics
The main advantage of trading using opposite Microsoft and Relief Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Relief Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relief Therapeutics will offset losses from the drop in Relief Therapeutics' long position.Microsoft vs. Global Blue Group | Microsoft vs. Aurora Mobile | Microsoft vs. Marqeta | Microsoft vs. Nextnav Acquisition Corp |
Relief Therapeutics vs. NRx Pharmaceuticals | Relief Therapeutics vs. NRX Pharmaceuticals | Relief Therapeutics vs. Pasithea Therapeutics Corp | Relief Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |